By adjusting SIRT1/PGC-1α signaling pathway, enhance liver antioxidant capacity and prevent the occurrence and development of non-alcoholic steatohepatitis (NASH) (26). The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatohepatitis.